Peptide therapy TikTok claims: separating hype from human data

What's this video probably claiming?

Without a transcript, we can make educated guesses based on the peptide category tag. Creators in this space typically run through a stack of compounds, often BPC-157, TB-500, CJC-1295, ipamorelin, or GHK-Cu, and present them as broadly safe, highly effective tools for recovery, anti-aging, and body composition. The framing tends to follow a pattern: these are "research peptides" that doctors don't want you to know about, or alternatively, that forward-thinking clinics are now prescribing. MK-677 often gets lumped in despite being a non-peptide small molecule. The overall message is usually that peptide therapy is a category of intervention with wide applicability and minimal downside. That framing deserves scrutiny before anyone acts on it.

What does the science actually show?

The honest answer is: it depends enormously on which peptide you're discussing, and for most of them, human trial data is thin to nonexistent. BPC-157 has been studied in rodent models showing accelerated tendon healing and gut mucosal repair (Sikiric et al., 2018, Current Pharmaceutical Design), but no completed randomized controlled trials in humans have been published. TB-500, a fragment of thymosin beta-4, shows pro-angiogenic effects in animal wound models (Philp et al., 2004, Annals of the New York Academy of Sciences), but again, human data is sparse. CJC-1295 combined with ipamorelin does produce measurable growth hormone pulses, with one small study showing mean GH increases of roughly 2-10 fold depending on dose (Teichman et al., 2006, Journal of Clinical Endocrinology and Metabolism). GHK-Cu has legitimate dermatology research behind it at topical concentrations. MK-677 is a ghrelin mimetic with documented IGF-1 elevation but also documented increases in fasting glucose and insulin resistance (Nass et al., 2008, Annals of Internal Medicine). The data is real, but it is nowhere near the clean efficacy narrative you hear on TikTok.

Where does the social media noise diverge from clinical reality?

Several places. First, creators routinely conflate animal-model findings with human outcomes. A rat healing a tendon faster after BPC-157 injection does not mean a human will. Second, the compounding pharmacy context gets glossed over entirely. Most of these peptides are available only through compounding pharmacies, which operate under different regulatory standards than FDA-approved drugs. Purity, concentration, and sterility vary. Third, MK-677 gets presented as a safe GH secretagogue alternative when the Nass et al. trial actually stopped early in elderly patients due to adverse cardiovascular and metabolic signals. Fourth, stacking multiple peptides is common advice in these videos, but no safety data exists for combination use. Fifth, the "no side effects" claim is simply not supportable. IGF-1 elevation from growth hormone secretagogues carries theoretical proliferative risk. That is not a fringe concern.

What should you actually know?

Peptide therapy is a legitimate area of clinical investigation that is being actively studied, and some compounds do have real mechanistic rationale. That is not the same as saying they are proven, safe for general use, or appropriate without medical supervision. If you are considering any of these compounds, the conversation starts with a physician who can order baseline IGF-1, glucose, and relevant metabolic labs. Growth hormone secretagogues like CJC-1295 and ipamorelin are not appropriate for anyone with active or prior malignancy, given IGF-1's role in cell proliferation. BPC-157 and TB-500 may have a future in clinical practice, but "may have a future" is not the same as "works now." MK-677 requires particular caution given the metabolic data. Semax and selank have even less human data and are largely unstudied outside Russian literature. Approach any TikTok peptide stack recommendation the same way you would approach financial advice from someone who got rich once.